Code Snippets
curl "https://financialdata.net/api/v1/earnings-releases?identifier=DHR&key=API_KEY"import requests
url = 'https://financialdata.net/api/v1/earnings-releases?identifier=DHR&key=API_KEY'
response = requests.get(url)
print(response.json())
const url = 'https://financialdata.net/api/v1/earnings-releases?identifier=DHR&key=API_KEY';
const response = await fetch(url);
const data = await response.json();
console.log(data);
Sample Response
[
{
"trading_symbol": "DHR",
"central_index_key": "0000313616",
"registrant_name": "DANAHER CORP /DE/",
"market_cap": 141667368700.0,
"fiscal_quarter_end_date": "2025-03",
"earnings_per_share": 1.88,
"earnings_per_share_forecast": 1.62,
"percentage_surprise": 16.05,
"number_of_forecasts": 10,
"conference_call_time": "2025-04-22 09:00:00"
},
...
]Query Parameters
| Name | Type | Description |
|---|---|---|
| identifier | string | The trading symbol for a security, or the central index key (CIK). The latter is assigned to the entity by the United States Securities and Exchange Commission. (e.g., MSFT, 0000789019) |
| format | string | (Optional) The format of the returned data, either JSON or CSV. Defaults to JSON. (e.g., json, csv) |
Endpoint Overview
An earnings release is an official public announcement revealing a company's profitability during a specific time period. It affects the share price, which rises or falls in response to the company's performance. Our API provides extensive information on the release, including actual and predicted earnings, release timing, and so on.
Company Profile
DANAHER CORP /DE/
NYSE: DHR- Market Cap:$125.90B
- ISIN:US2358511028
- Fiscal Year End:12/31
- CEO:Rainer Blair
- Employees:63000
Danaher Corporation is an American healthcare company headquartered in Washington, D.C.. It develops products used for advances in biotechnology, life sciences, and diagnostics. The company operates three divisions: biotechnology (28% of 2024 revenues), which develops products for the development of therapeutics; life sciences (31% of 2024 revenues), which develops products to identify causes of disease, new therapies, and to test and manufacture new drugs, vaccines and gene editing technologies; and diagnostics (41% of 2024 revenues), which develops instruments, consumables, and software and services to diagnose diseases. Danaher was founded in 1984 by brothers Steven Rales and Mitchell Rales; it was named after Danaher Creek in Western Montana, where the brothers came up with the idea for the company while fishing.